{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:58:13Z","timestamp":1777409893166,"version":"3.51.4"},"reference-count":24,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Autoimmune blistering diseases are a group of severe mucocutaneous conditions that typically require the use of prolonged corticosteroids and immunosuppression. Properly managing associated comorbidities is an integral part of these patients\u2019 care. The frequency of gastrointestinal symptoms, particularly gastrointestinal bleeding in these patients, is not known. Likewise, the effect of diet on disease is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine the incidence of gastrointestinal comorbidities and the role of diet in patients with autoimmune blistering disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We distributed an e\u2010survey to patients with autoimmune blistering disease utilizing the International Pemphigus and Pemphigoid Foundation's listserv. The incidence of gastrointestinal symptoms and gastrointestinal bleeding were recorded, as were foods avoided and those noted to be beneficial in patients' disease. Historical incidences in the general population were used as controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 200 responses were collected. 30.3% of patients experienced gastroesophageal reflux following treatment of their autoimmune blistering disease, with 51.7% utilizing some form of gastrointestinal symptomatic treatment. The incidence of gastrointestinal bleeding following an autoimmune blistering diagnosis was 2.1%, which remained significant despite correction for non\u2010steroidal anti\u2010inflammatory use (<jats:styled-content style=\"fixed-case\">NSAID<\/jats:styled-content>), but not corticosteroid use. 65.2% of patients reported dietary limitations because of their autoimmune blistering disease. Significant intolerances after correction for multiple comparisons included alcohol, citrus and spicy foods. Greater than 10% of patients reported improvements in their disease with vegetables and dairy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Gastrointestinal comorbidities are common in patients with autoimmune blistering diseases, with gastrointestinal bleeding occurring in 2.1% of patients following a diagnosis of autoimmune blistering disease. While further work is needed to determine the relative risk of routine gastrointestinal prophylaxis in this population, gastrointestinal bleeding prophylaxis should be considered in patients receiving corticosteroids, particularly those taking <jats:styled-content style=\"fixed-case\">NSAID<\/jats:styled-content>s. Dietary limitations are additionally frequent in this population. Patients should be cautious of alcohol, citrus and spicy foods.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.15731","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T15:13:50Z","timestamp":1559834030000},"page":"1935-1940","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gastrointestinal symptoms, gastrointestinal bleeding and the role of diet in patients with autoimmune blistering disease: a survey of the International Pemphigus and Pemphigoid Foundation"],"prefix":"10.1111","volume":"33","author":[{"given":"D.","family":"Kneiber","sequence":"first","affiliation":[{"name":"Department of Dermatology University of Illinois at Chicago Chicago IL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.H.","family":"Kowalski","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Illinois at Chicago Chicago IL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9971-9151","authenticated-orcid":false,"given":"K.","family":"Kridin","sequence":"additional","affiliation":[{"name":"Department of Dermatology Rambam Healthcare Campus Haifa Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Yale","sequence":"additional","affiliation":[{"name":"International Pemphigus and Pemphigoid Foundation Sacramento CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"Grando","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California Irvine Irvine CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2906-2454","authenticated-orcid":false,"given":"K.T.","family":"Amber","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Illinois at Chicago Chicago IL USA"},{"name":"Department of Dermatology University of California Irvine Irvine CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0343-4"},{"issue":"12","key":"e_1_2_5_3_1","article-title":"Association of pemphigus and systemic corticosteroid use with comorbid health disorders: a case\u2010control study","volume":"23","author":"Hsu DY","year":"2017","journal-title":"Dermatol Online J"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.2808"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14821"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23424"},{"key":"e_1_2_5_7_1","first-page":"879","article-title":"Osteoporosis in patients with pemphigus vulgaris before steroid therapy","volume":"52","author":"Ghodsi SZ","year":"2014","journal-title":"Acta Med Iran"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15005"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.354"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v5.i4.467"},{"key":"e_1_2_5_11_1","first-page":"A5540","article-title":"Concomitant use of proton pump inhibitors and systemic corticosteroids","volume":"157","author":"Dorlo TP","year":"2013","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004587"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.09.011"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90131-7"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.0603"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001872"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155020"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14190"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2016.57"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13041"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304269"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/63.5.741"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw106"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22965"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu9040341"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.15731","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.15731","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.15731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T15:40:13Z","timestamp":1693928413000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.15731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1111\/jdv.15731"],"URL":"https:\/\/doi.org\/10.1111\/jdv.15731","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"2018-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}